ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Podiatrist, Foot Surgery

Top Podiatrist, Foot Surgery Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAM HOROWITZ DPM FACFAS CPED

Podiatrist, Foot Surgery

3,929

$148K

1343
1191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 13%

$38
Average prescription price

Avg: $39

EUGENE FOX DPM

Podiatrist, Foot Surgery

2,019

$98.5K

522
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 13%

$49
Average prescription price

Avg: $39

JAVIER MARIBONA D.P.M.

Podiatrist, Foot Surgery

1,784

$66.2K

886
852 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 13%

$37
Average prescription price

Avg: $39

NANCY ALEXIS-CALIXTE DPM

Podiatrist, Foot Surgery

1,612

$56.7K

580
506 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 13%

$35
Average prescription price

Avg: $39

WILLIAM VIVAS DPM

Podiatrist, Foot Surgery

1,136

$41.9K

415
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 13%

$37
Average prescription price

Avg: $39

NAILA ESMAIL DPM

Podiatrist, Foot Surgery

1,047

$29.1K

280
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

3%
prescriptions for brand name drugs

Avg: 13%

$28
Average prescription price

Avg: $39

MARIAINES APOLO DPM

Podiatrist, Foot Surgery

1,003

$30.9K

273
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 13%

$31
Average prescription price

Avg: $39

FRANCISCO OLIVA D.P.M.

Podiatrist, Foot Surgery

987

$47.6K

358
315 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 13%

$48
Average prescription price

Avg: $39

LUIS EIBER D.P.M.

Podiatrist, Foot Surgery

963

$26.5K

323
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 13%

$28
Average prescription price

Avg: $39

GILBERTO ACOSTA DPM

Podiatrist, Foot Surgery

952

$77.3K

260
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 13%

$81
Average prescription price

Avg: $39

CHARLTON ADLER D.P.M

Podiatrist, Foot Surgery

719

$27.1K

200
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 13%

$38
Average prescription price

Avg: $39

JOEL LEVY DPM

Podiatrist, Foot Surgery

611

$19.4K

269
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 13%

$32
Average prescription price

Avg: $39

MELISSA PERLMAN DPM

Podiatrist, Foot Surgery

603

$26.6K

255
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 13%

$44
Average prescription price

Avg: $39

FRANK CASTAGNA DPM

Podiatrist, Foot Surgery

492

$6,932

197
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

3%
prescriptions for brand name drugs

Avg: 13%

$14
Average prescription price

Avg: $39

FLAVIA INESTA DPM

Podiatrist, Foot Surgery

462

$29K

162
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 13%

$63
Average prescription price

Avg: $39

ROBERT VALINS D.P.M., P.A.

Podiatrist, Foot Surgery

452

$13.8K

246
189 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 13%

$30
Average prescription price

Avg: $39

GABRIELLE GAGLIARDI D.P.M.

Podiatrist, Foot Surgery

428

$12.7K

197
148 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 13%

$30
Average prescription price

Avg: $39

ANTHONY EMELIANCHIK DPM

Podiatrist, Foot Surgery

424

$12.8K

119
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 13%

$30
Average prescription price

Avg: $39

JULIO ORTIZ DPM

Podiatrist, Foot Surgery

420

$18.4K

151
123 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 13%

$44
Average prescription price

Avg: $39

GARY WALLACH DPM

Podiatrist, Foot Surgery

409

$8,329

159
128 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 13%

$20
Average prescription price

Avg: $39

BRUCE COHEN D.P.M.

Podiatrist, Foot Surgery

402

$18.3K

217
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$46
Average prescription price

Avg: $39

MATTHEW ETHERIDGE D.P.M

Podiatrist, Foot Surgery

401

$38.6K

186
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 13%

$96
Average prescription price

Avg: $39

KEITH KALISH DPM

Podiatrist, Foot Surgery

367

$3,395

218
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

5%
prescriptions for brand name drugs

Avg: 13%

$9
Average prescription price

Avg: $39

IAN KLEIN D.P.M.

Podiatrist, Foot Surgery

367

$15.4K

136
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 13%

$42
Average prescription price

Avg: $39

LORRAINE FARKAS WEISSBERG DPM

Podiatrist, Foot Surgery

365

$10.9K

170
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 13%

$30
Average prescription price

Avg: $39

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank